Impact Factor
3.43
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.01
451 total citations
h5-index
24
h5 depth signal
Cited share
79.5%
128 of 161
Total citations
451
Citation footprint
Metric signal
3.63
External metric anchor
Self-citation
1.6%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
165
China
128
India
42
Iran
42
Japan
40
Citing Fields of Research
Molecular & Cellular Toxicology
261
Lipids
183
Diabetes
71
Immunology
63
Cardiology
52
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,008
Articles tracked across the journal lifetime
Indexed publication set
161
128 cited publications
Last 12 months
48
4.4 publications/month
Open access share
20.8%
10 OA publications in the last year
Leading citing country
United States
165 citing publications
Leading citing field
Molecular & Cellular Toxicology
261 citing publications
Latest tracked publication
2 October 2026
10 recent records available
Coverage & Indexing History
v55n1,Jan. 1998-
v55n1,Jan. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Lipids
Molecular & Cellular Toxicology
Diabetes
Phytochemicals
Immunology
Osteopathies
Broad Categories
Endocrinology
Molecular & Cellular Toxicology
Lipids
Phytochemicals
Endocrine Therapy
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Cell Communication
Lipid Metabolism
Prostaglandins
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.prostaglandins.2026.107116
Open DOI
Cracking the Code of Cravings: Endocannabinoids and the Hypothalamic Appetite Nexus
02
DOI 10.1016/j.prostaglandins.2026.107107
Open DOI
Lifelong caloric restriction reshapes age-related hepatic oxylipin profiles and is associated with a CYB5R3-linked epoxide–diol signature
03
DOI 10.1016/j.prostaglandins.2026.107112
Open DOI
Editorial Board
04
DOI 10.1016/j.prostaglandins.2026.107115
Open DOI
EpOMEs compromise colonic homeostasis through microbiome dysbiosis and inflammatory activation
05
DOI 10.1016/j.prostaglandins.2026.107106
Open DOI
Bioactive compounds of Oroxylum indicum ( L.) Kurz stem bark and their anti-inflammatory significance
06
DOI 10.1016/j.prostaglandins.2026.107105
Open DOI
Spatial remodeling of the sphingolipid rheostat in colorectal carcinogenesis
07
DOI 10.1016/j.prostaglandins.2026.107104
Open DOI
Role of Prostaglandins in Androgenetic Alopecia
08
DOI 10.1016/j.prostaglandins.2026.107103
Open DOI
Antibiotic-induced disruption of lipid mediator signaling: Implications for cardiovascular inflammation and cardiotoxicity
09
DOI 10.1016/j.prostaglandins.2026.107102
Open DOI
Fatty acid metabolites concentration in the early phase of myocardial infarction and its relation to left ventricular ejection fraction.
10
DOI 10.1016/j.prostaglandins.2026.107101
Open DOI
Daily Topical Latanoprost Free Acid Exacerbates Retinal Ganglion Cell Degeneration in the DBA/2J Mouse Model of Pigment Dispersion Glaucoma
Bibliographical & Catalog Notes
Title from cover.
Continues the numbering of: Prostaglandins.
Also issued online.
Merger of: Prostaglandins, and: Journal of lipid mediators and cell signalling.